Can a ketogenic diet help improve survival for GBMs? “Previous studies showed that GBM survival and tumor growth was correlated with blood glucose levels, i.e., the higher was the blood glucose, the shorter was the survival, and the faster was the tumor growth…” Read more here.
Author: angela
Glioblastoma Patients in Fort Pierce
This is an interesting article about 13 cases of GBM in the Fort Pierce community. Read and watch the full story here.
New Immunotherapy Clinical Trial
A new clinical trial using immunotherapy is taking place at the National Hospital for Neurology and Neurosurgery in Bloomsbury. It is said that, “This is the most important trial for brain cancer patients in the last 15 years.” Read more.
Clinical Trial Recruiting Patients
The Center for Neuro-Oncology at the Dana-Farber Cancer Institute in Boston is recruiting newly diagnosed patients for a clinical trial using three new drugs. They are hoping that these drugs will improve survival for patients with glioblastoma. For more information follow this link.
Treating Glioblastoma with Salmonella
Duke researchers are using salmonella bacteria to fight glioblastoma. Read the full article here.
An Evening of Inspiration
Yesterday was the second annual Glioblastoma Multiforme (GBM) Heroes Awards, honoring individuals who have dedicated their lives to helping patients suffering from glioblastoma. Read the full article here.
Upcoming Webinar
The ABTA presents: New Global Classification of Brain Tumors Improve Diagnosis and Treatment. To register please follow this link.
Text FIGHT to 20222 to Donate to Brain Cancer Research!
The Canadian Cancer Society has partnered with Bell Media, Corus Entertainment, NewCap Radio, Rawlco Radio and Maritime Broadcasting System Radio to create a text-to-give campaign. By texting FIGHT to 20222, you can donate $10, $20, or $25 towards brain cancer research. To learn more, visit this link.
Understanding Glioblastoma from MD Anderson Cancer Center
Researchers Develop New Therapy Using a Vaccine
Researchers at UCLA are developing a breakthrough treatment using a vaccine to help attack GBM cells. Read the full article here: UCLA researchers develop new combination therapy to activate immune response against glioblastoma